Opendata, web and dolomites

MalaDiag

Development of a very rapid diagnostic test for malaria, based on break-through detection technology and new biomarkers of infection.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "MalaDiag" data sheet

The following table provides information about the project.

Coordinator
VAXIMAX 

Organization address
address: 4 RUE PIERRE FONTAINE CAMPUS 3
city: Evry
postcode: 91058
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-12-01   to  2015-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VAXIMAX FR (Evry) coordinator 50˙000.00
2    METEMIS DEVELOPMENT FR (EVRY) participant 0.00

Map

 Project objective

The overall project objective is to develop and bring to market a very rapid diagnostic test (V-RDT) for malaria, based on break-through detection technology and particularly relevant biomarkers of infection.

Our ambition is for our diagnostic device to become the reference technology in all malaria endemic areas.

A key advantage of our approach lies in the combination of an innovative detection device with novel biomarkers that should significantly improve the quality of testing and the ability to implement mass testing campaigns.

Our device is expected to overcome most shortcomings identified in devices currently on the market. The expected added value of our proposed diagnostic device to users is multiple including: • Rapidity: 1 minute vs. 15-20 minutes required for most current tests. This is a major competitive advantage for cross-sectional testing necessary for eradication efforts; • High sensitivity including quantitative evaluations (picomolar detection); • Several simultaneous measures to distinguish parasite species (P. falciparum / P. vivax); • Infection parameters (parasite density and antibody response): the comprehensive nature of our diagnostic read-outs provide information on prognosis and/or therapeutic response in addition to simple yes/no diagnoses; and • Functional and reliable in expected field conditions (tropical environments). .

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MALADIAG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MALADIAG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

PD_Pal (2019)

Palliative care in Parkinson’s disease

Read More